PREVALENCE AND CLINICAL COURSE OF CHRONIC HEART FAILURE AMONG THE POPULATION OF ANDIJAN REGION
Main Article Content
Abstract
Chronic heart failure (CHF) is one of the most important medical and social problems in the modern healthcare system. This syndrome is characterized by the inability of the heart’s pumping function to fully meet the tissues’ demand for oxygen and nutrients. CHF is associated not only with the disease itself but also with disability, premature death, and increased economic burden. Worldwide, the prevalence of heart failure continues to grow yearly, which is closely related to population aging, an increase in comorbid conditions, and lifestyle factors. Therefore, assessing the prevalence of CHF, evaluating risk factors, and studying its clinical course are considered priorities not only in global but also in regional healthcare policy. Particular attention is being paid to studying the prevalence of CHF at the local level and the factors influencing its clinical course.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Polyakov D.S., Fomin I.V., Belenkov Yu.N. Chronic heart failure in the Russian Federation: what has changed over 20 years of observation? Results of the EPOCH-CHF study // Kardiologiya. – 2021. – Vol. 61, No. 2. – Pp. 4–15.
2.Mareev V.Yu., Ageev F.T., Arutyunov G.P., et al. National guidelines of OSSN, RKO, and RNMOT on the diagnosis and treatment of chronic heart failure (fourth revision) // Journal Heart Failure. – 2020. – Vol. 21, No. 3. – Pp. 112–164.
3.McDonagh T.A., Metra M., Adamo M., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // European Heart Journal. – 2021. – Vol. 42. – Pp. 3599–3726.
4.Heidenreich P.A., Bozkurt B., Aguilar D., et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.